Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BRTX stock hub

BioRestorative Therapies, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BRTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BRTX

In the news

Latest news · BRTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-320.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-219

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BRTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001505497
Company name	BioRestorative Therapies, Inc.
Country	United States
Country code	US
Cusip	090655606
Employees	14
Employees Change	3%
Employees Change Percent	27.27
Enterprise value	$2.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US0906556065
Last refreshed	2026-05-10
Market cap	$5.2M
Market cap category	Nano-Cap
Price	$0.21
Price currency	USD
Rev Per Employee	25,692.86x
Sector	Healthcare
Sic	8090
Symbol	BRTX
Website	https://www.biorestorative.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-271.62%
EV Sales Forward	1.63x
EV/Sales	6.49x
FCF yield	-207.98%
P/B ratio	5.33x
P/S ratio	14.58x
PS Forward	3.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	93.37%
Gross Profit	$335,856
Gross Profit Growth	-9.94%
Gross Profit Growth Q	-55.05%
Gross Profit Growth3 Y	41%
Gross Profit Growth5 Y	34.26%
Net Income	$-14.2M
Net Income Growth Years	0%
Pretax Margin	-3,959.4%
Profit Per Employee	$-1M
ROA	-119.6
Roa5y	-85.36
ROCE	-4,386.1
ROE	-320.5
Roe5y	-208
ROIC	-219

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-67.58%
Cagr15y	-57.51%
Cagr1y	-88.58%
Cagr3y	-63.96%
Cagr5y	-64.25%
EPS Growth Years	0
Revenue Growth	-10.3x
Revenue Growth Q	-54.73x
Revenue Growth Years	0x
Revenue Growth3 Y	44.27x
Revenue Growth5 Y	36.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.04
Assets	$4.1M
Cash	$3M
Current Assets	$3.1M
Current Liabilities	$3.7M
Debt	$42,282
Debt Equity	$0.12
Equity	$356,744
Liabilities	$3.7M
Long Term Assets	$942,773
Long Term Liabilities	$0
Net Cash	$2.9M
Net Cash By Market Cap	$55.51
Net Cash Growth	-72.88%
Net Debt Equity	$-8.16
Tangible Book Value	$-191,436
Tangible Book Value Per Share	$-0.02
WACC	5.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.84
Net Working Capital	$-3.5M
Quick ratio	0.8
Working Capital	$-586,029
Working Capital Turnover	$0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.83%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-88.57%
200-day SMA	1.02
3Y total return	-95.32%
50-day SMA	0.25
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.42%
All Time High	400,000
All Time High Change	-100%
All Time High Date	2009-06-02
All Time Low	0.19
All Time Low Change	8.32%
All Time Low Date	2026-02-23
ATR	0.03
Beta	0.2
Beta1y	0.25
Beta2y	1.03
Ch YTD	-82.49
High	0.24
High52	2.05
High52 Date	2025-06-12
High52ch	-89.94%
Low	0.21
Low52	0.19
Low52 Date	2026-02-23
Low52ch	8.32%
Ma50ch	-18.4%
Premarket Change Percent	6.49
Premarket Price	$0.24
Premarket Volume	73,865
Price vs 200-day SMA	-79.84%
RSI	37.96
RSI Monthly	27.89
RSI Weekly	23.05
Sharpe ratio	-1.35x
Sortino ratio	-1.65
Total Return	-15.83%
Tr YTD	-82.49
Tr15y	-100%
Tr1m	-17.91%
Tr1w	-11.77%
Tr3m	-80.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.3
Earnings Revenue Estimate	260,000x
Earnings Revenue Estimate Growth	940x
Operating Income	$-15.6M
Operating margin	-4,350.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24,175,254%
Float Percent	94.89%
Shares Insiders	3.24%
Shares Institutions	11.61%
Shares Out	25,478,170
Shares Qo Q	6.91%
Shares Yo Y	15.83%
Short Float	2.68%
Short Ratio	0.25
Short Shares	2.54

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-14.2M
Average Volume	1,215,262.55x
Bv Per Share	0.04
CAPEX	$-116,069
Ch10y	-100
Ch15y	-100
Ch1m	-17.91
Ch1w	-11.79
Ch1y	-88.57
Ch3m	-80.21
Ch3y	-95.32
Ch5y	-99.42
Ch6m	-84.98
Change	-8.53%
Change From Open	-10.52
Close	0.23
Days Gap	2.22
Depreciation Amortization	209,985
Dollar Volume	332,083.8
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-15.6M
EBITDA	$-15.4M
EPS	$-1.58
F Score	3
FCF	$-10.9M
FCF EV Yield	-467.47x
FCF Per Share	$-0.43
Financing CF	2,854,791
Fiscal Year End	December
Founded	1,997
Investing CF	8,897,470
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Date	2021-10-27
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	0.85
Ma150ch	-75.88%
Ma20	0.24
Ma20ch	-13.31%
Net CF	963,298
Next Earnings Date	2026-05-22
Open	0.23
Optionable	No
Position In Range	0
Post Close	0.21
Postmarket Change Percent	0.1
Postmarket Price	$0.21
Ppne	358,767
Pre Close	0.23
Price Date	2026-05-08
Relative Volume	1.33x
Revenue	359,700x
SBC By Revenue	924.56x
Share Based Comp	3,325,626
Tr6m	-84.98%
Us State	New York
Volume	1,613,624
Z Score	-69.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BRTX pay a dividend?

Capital-return profile for this ticker.

Performance

BRTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BRTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.6%

Float: +94.9% of shares outstanding

Insider ownership

+3.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BRTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.0

Neutral momentum band

Price vs 200-day MA

-79.8%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

-1.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BRTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BRTX stock rating?

BioRestorative Therapies, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BRTX analysis?

The full report lives at /stocks/BRTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BRTX?

The latest report frames BRTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BRTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.